Rutin
13 benefits mapped to clinical evidence across supplements.
Dose per serving from products
1,187 products in our catalogue print how much Rutin a serving holds.
Most common: 10 mg to 25 mg, 27% of 1,187 products.
| Dose per serving | Products |
|---|---|
| 2.5 mg or less | 54 |
| 2.5 mg to 5 mg | 179 |
| 5 mg to 10 mg | 115 |
| 10 mg to 25 mg | 324 |
| 25 mg to 50 mg | 220 |
| 50 mg to 100 mg | 171 |
| 100 mg to 250 mg | 78 |
| over 250 mg | 46 |
Dose per serving from research
39 study groups in 27 studies say how much Rutin participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 500 mg to 1 g, 38% of 39 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mg or less | 1 |
| 100 mg to 250 mg | 3 |
| 250 mg to 500 mg | 8 |
| 500 mg to 1 g | 15 |
| 1 g to 2.5 g | 10 |
| over 2.5 g | 2 |
Benefit Evidence
Research sources
Blood circulation (24)
- The LONFLIT4-VENORUTON study: a randomized trial prophylaxis of flight-edema in normal subjects
PubMed ID: 12643319
Venoruton markedly reduced flight-related leg swelling and symptoms in healthy travellers (consistent objective and subjective effects).
- The LONFLIT4-Venoruton Study: a randomized trial--prophylaxis of flight-edema in venous patients
PubMed ID: 12678187
Venoruton (hydroxyethylrutosides) substantially reduced long‑haul flight leg swelling and discomfort (objective protection of circulation).
- HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial
PubMed ID: 12011966
HR reduced microcirculatory abnormalities, ankle swelling and symptoms in venous hypertension.
- Oxerutins (Venoruton): efficacy in chronic venous insufficiency--a double-blind, randomized, controlled study
PubMed ID: 12025912
Oxerutins improved venous capacity and LRR with objective microcirculatory improvements vs placebo.
- Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial
PubMed ID: 12011969
Dose-ranging HR trial showed dose-dependent reduction in capillary filtration and symptom improvement.
- Flight microangiopathy in medium-to-long distance flights: prevention of edema and microcirculation alterations with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective, randomized, controlled trial
PubMed ID: 12011968
HR preserved transcutaneous Po2, resting flux and venoarteriolar responses during long flights.
- Parenteral troxerutin and carbazochrome combination in the treatment of post-hemorrhoidectomy status: a randomized, double-blind, placebo-controlled, phase IV study
PubMed ID: 11922398
Troxerutin+carbazochrome injection reduced bleeding and related postoperative signs vs placebo.
- [Effectiveness and safety of hydroxyethyl-rutosides in the local treatment of symptoms of venous insufficiency during air travel]
PubMed ID: 10467532
Topical hydroxyethyl-rutoside gel reduced ankle circumference and symptoms during long flights vs placebo.
- Investigation of the therapeutic equivalence of different galenical preparations of O-(beta-hydroxyethyl)-rutosides following multiple dose peroral administration
PubMed ID: 8737632
Different HR oral formulations significantly reduced leg-volume (edema) vs placebo.
- Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings
PubMed ID: 8737630
Adding oxerutins to compression stockings produced significantly greater edema reduction vs stockings alone (large RCT—clinical circulation benefit).
- Fibrinolysis and hemorheology in chronic venous insufficiency: a double blind study of troxerutin efficiency
PubMed ID: 7593149
Randomized trial: troxerutin reduced RBC aggregation and improved fibrinolysis markers—strong mechanistic support for improved circulation.
- A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin
PubMed ID: 7943118
In retinal vein occlusion troxerutin improved macular edema and reduced RBC aggregation—clinical and rheological indicators of improved local blood flow.
- Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability
PubMed ID: 8034203
DB trial in elderly with venous insufficiency: symptom score and ankle/calf swelling reduced more than placebo (clinical circulation endpoints).
- Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency
PubMed ID: 7975870
Meta-analysis: hydroxyethylrutosides modestly but significantly improved leg pain, swelling and tired legs—consistent circulatory benefit across trials.
- Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study)
PubMed ID: 1580094
Clear, dose-dependent reductions in capillary filtration (microvascular permeability)—strong microcirculatory evidence.
- [Effectiveness of the combination of alpha tocopherol, rutin, melilotus, and centella asiatica in the treatment of patients with chronic venous insufficiency]
PubMed ID: 11292962
Multi-ingredient product including rutin reduced leg swelling and symptoms in CVI; contribution of rutin plausible but not isolated.
- Veno-active drugs for chronic venous disease: A randomized, double-blind, placebo-controlled parallel-design trial
PubMed ID: 23761871
Veno-active drugs as a class improved venous disease QoL; troxerutin-containing arm included though agent-specific effects mixed.
- HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study
PubMed ID: 15678250
Hydroxyethylrutosides produced large reductions in resting skin flux, ankle swelling rate and symptom scores vs comparator (strong microcirculatory evidence).
- HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial
PubMed ID: 12232562
Large randomized comparison showed Venoruton improved objective microcirculatory parameters (RF, RAS) vs diosmin.
- Calcium dobesilate and oxerutin: effectiveness of combination therapy
PubMed ID: 20348452
Combination including oxerutin reduced venous symptoms more than single agents (support for venous circulation symptom relief).
- An open-label, randomized multicenter study comparing the efficacy and safety of Cyclo 3 Fort versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency
PubMed ID: 10917578
Combination product outperformed rutoside alone, but rutoside still had measurable circulation effects.
- Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
PubMed ID: 41197809
Oxerutin reduced residual venous obstruction after DVT, supporting improved venous blood flow and thrombus resolution.
- Flight microangiopathy on long-haul flights: prevention of edema and microcirculation alterations with Venoruton
PubMed ID: 12812378
Hydroxyethylrutosides reduced flight-associated microcirculatory deterioration and limited ankle swelling (objective microvascular protection).
- The efficiency of O-(beta-hydroxyethyl)-rutosides in reducing the incidence of superficial venous insufficiency in patients with calf muscle pump dysfunction
PubMed ID: 26924360
Oxerutin strongly reduced superficial venous reflux incidence during immobilization, indicating improved venous flow/health.
Swelling relief (18)
- Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability
PubMed ID: 8034203
Elderly CVI trial showed significant reduction in ankle/calf circumference compared with placebo (clinical edema endpoint).
- HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial
PubMed ID: 12011966
HR decreased rate of ankle swelling and improved symptoms in venous hypertensive patients.
- Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial
PubMed ID: 12011969
Dose-dependent reduction in capillary filtration and ankle edema documented.
- Flight microangiopathy in medium-to-long distance flights: prevention of edema and microcirculation alterations with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective, randomized, controlled trial
PubMed ID: 12011968
HR prevented ankle swelling during long flights in varicose patients.
- Parenteral troxerutin and carbazochrome combination in the treatment of post-hemorrhoidectomy status: a randomized, double-blind, placebo-controlled, phase IV study
PubMed ID: 11922398
Intramuscular troxerutin combo significantly reduced postoperative swelling after hemorrhoid surgery.
- [Effectiveness and safety of hydroxyethyl-rutosides in the local treatment of symptoms of venous insufficiency during air travel]
PubMed ID: 10467532
Topical HR gel reduced ankle circumference and edema signs vs placebo in a crossover trial.
- Investigation of the therapeutic equivalence of different galenical preparations of O-(beta-hydroxyethyl)-rutosides following multiple dose peroral administration
PubMed ID: 8737632
Multiple HR oral preparations significantly reduced leg-volume vs placebo after 12 weeks.
- Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings
PubMed ID: 8737630
Well-sized randomized DB study: oxerutins + stockings produced significantly greater leg-volume reduction vs stockings alone.
- [Effectiveness of beta-hydroxyethylrutoside in patients with varicose veins in pregnancy]
PubMed ID: 7778354
Pregnancy study reported reductions in leg circumference and symptom scores with hydroxyethylrutosides (supporting edema reduction).
- Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency
PubMed ID: 7975870
Meta-analysis: hydroxyethylrutosides modestly but significantly improved swelling vs placebo across multiple trials.
- Leg oedema protection from a buckwheat herb tea in patients with chronic venous insufficiency: a single-centre, randomised, double-blind, placebo-controlled clinical trial
PubMed ID: 8858269
Buckwheat (rutin-rich) tea prevented worsening of leg swelling vs placebo in CVI (RCT; modest protective effect).
- [Effectiveness of the combination of alpha tocopherol, rutin, melilotus, and centella asiatica in the treatment of patients with chronic venous insufficiency]
PubMed ID: 11292962
Combination including rutin reduced leg swelling and symptoms in chronic venous insufficiency (open randomized; rutin contribution plausible).
- Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial
PubMed ID: 25893991
Troxerutin-containing flavonoid mix reduced pain, bleeding and edema persistence in acute hemorrhoid crisis (randomized triple‑blind trial).
- Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency
PubMed ID: 16518519
Oxerutins produced marked improvement in venous-related QoL and reduced edema vs comparator (clinically meaningful edema reduction).
- A prospective, randomized, double-blind, placebo-controlled clinical trial comparing the efficacy of systemic enzyme therapy for edema control in orthognathic surgery using ultrasound scan to measure facial swelling
PubMed ID: 23566694
Systemic enzyme therapy reduced postoperative facial soft‑tissue swelling more than placebo (small RCT).
- The LONFLIT4-VENORUTON study: a randomized trial prophylaxis of flight-edema in normal subjects
PubMed ID: 12643319
Venoruton markedly limited flight-related ankle increases and symptoms in healthy travellers (strong edema prevention).
- The LONFLIT4-Venoruton Study: a randomized trial--prophylaxis of flight-edema in venous patients
PubMed ID: 12678187
Venoruton greatly reduced flight-associated leg swelling and subjective discomfort (large and clinically relevant edema reduction).
- The efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: a double blind placebo-controlled randomised study
PubMed ID: 12236023
Combination drug (coumarin + troxerutin) reduced leg-volume recurrence and improved complaint scores vs placebo after stopping compression (objective edema benefit).
Vascular health (17)
- Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial
PubMed ID: 25893991
Troxerutin-related flavonoid mix improved hemorrhoid outcomes (pain, bleeding, edema), consistent with strengthened venous/hemorrhoidal integrity.
- Flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) in the treatment of I-III degree hemorroidal disease: a double-blind multicenter prospective comparative study
PubMed ID: 29934701
Large RCT with a rutin-containing mix improved hemorrhoid-related outcomes and satisfaction vs comparator, supporting venous symptom benefit (multi‑ingredient).
- Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study)
PubMed ID: 1580094
Controlled dose-comparison study showed rapid, dose-dependent reductions in capillary filtration (direct evidence of strengthened capillary barrier).
- Fibrinolysis and hemorheology in chronic venous insufficiency: a double blind study of troxerutin efficiency
PubMed ID: 7593149
Troxerutin improved RBC aggregation and fibrinolysis markers which support reduced venous stasis and venous health.
- Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings
PubMed ID: 8737630
Oxerutins added to stockings led to greater edema reduction than stockings alone (clinical improvement in venous disease consistent with enhanced venous function/integrity).
- Parenteral troxerutin and carbazochrome combination in the treatment of post-hemorrhoidectomy status: a randomized, double-blind, placebo-controlled, phase IV study
PubMed ID: 11922398
Troxerutin-containing injection improved postoperative venous/hemorrhoidal outcomes vs placebo.
- Trihydroxyethylrutosides in the treatment of hemorrhoids of pregnancy: a double-blind placebo-controlled trial
PubMed ID: 11804247
HR improved hemorrhoid symptoms in pregnancy vs placebo, indicating venous support in pelvic venous beds.
- Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial
PubMed ID: 12011969
Dose-dependent reduction in capillary filtration rate and edema demonstrates robust capillary/vascular mechanical effects.
- Oxerutins (Venoruton): efficacy in chronic venous insufficiency--a double-blind, randomized, controlled study
PubMed ID: 12025912
Oxerutins improved venous capacity and capillaroscopy/temperature, supporting venous structural/functional benefit.
- HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial
PubMed ID: 12011966
HR reduced microcirculatory abnormalities and edema in venous hypertensive patients—supports vein function integrity.
- The efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: a double blind placebo-controlled randomised study
PubMed ID: 12236023
Coumarin + troxerutin combination reduced leg-volume recurrence and improved complaints after compression cessation (supports venous function).
- The efficiency of O-(beta-hydroxyethyl)-rutosides in reducing the incidence of superficial venous insufficiency in patients with calf muscle pump dysfunction
PubMed ID: 26924360
Oxerutin substantially lowered incidence of superficial venous reflux in immobilized patients (strong RCT evidence for venous protection).
- Flight microangiopathy on long-haul flights: prevention of edema and microcirculation alterations with Venoruton
PubMed ID: 12812378
Hydroxyethylrutosides limited flight-associated microcirculatory changes (supports capillary protection in acute stress).
- Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
PubMed ID: 41197809
Oxerutin reduced residual venous obstruction after DVT and lowered vascular inflammatory biomarkers, supporting improved vein healing/integrity.
- HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial
PubMed ID: 12232562
Venoruton improved objective microcirculatory parameters and symptoms in chronic venous disease.
- HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study
PubMed ID: 15678250
Hydroxyethylrutosides improved microcirculatory measures and symptoms vs comparator—consistent with enhanced venous/capillary integrity.
- Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency
PubMed ID: 16518519
Oxerutins produced large improvements in venous-related QoL and edema, supporting vein integrity/venotonic benefit (moderate evidence).
Inflammation (6)
- Parenteral troxerutin and carbazochrome combination in the treatment of post-hemorrhoidectomy status: a randomized, double-blind, placebo-controlled, phase IV study
PubMed ID: 11922398
Intramuscular troxerutin+carbazochrome significantly reduced pain, bleeding and swelling after hemorrhoid surgery.
- Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
PubMed ID: 41197809
Oxerutin lowered inflammatory biomarkers (ICAM‑1, IL‑6) in DVT study, suggesting anti-inflammatory vascular effects.
- The effects of rutin flavonoid supplement on glycemic status, lipid profile, atherogenic index of plasma, brain-derived neurotrophic factor (BDNF), some serum inflammatory, and oxidative stress factors in patients with type 2 diabetes mellitus: A double-blind, placebo-controlled trial
PubMed ID: 36101997
Rutin reduced IL‑6 and other inflammatory markers in T2DM patients.
- Study of the soothing effects of troxerutin in alleviating skin sensitivity
PubMed ID: 38720512
Troxerutin reduced capsaicin/heat-induced skin irritation and molecular markers of irritation/inflammation in clinical testing.
- Eating buckwheat cookies is associated with the reduction in serum levels of myeloperoxidase and cholesterol: a double blind crossover study in day-care centre staffs
PubMed ID: 21931228
Tartary buckwheat (high in rutin) reduced serum MPO (~16%), an inflammation/oxidative marker (moderate evidence).
- A clinical trial of hydroxyethylrutosides in the treatment of haemorrhoids of pregnancy
PubMed ID: 1568520
Well-powered RCT in pregnant patients: hydroxyethylrutosides reduced haemorrhoid symptoms/signs (anti-inflammatory and symptomatic effects).
Antioxidant (5)
- Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized trial
PubMed ID: 12011970
Hydroxyethylrutoside trial demonstrated decreased plasma free radicals vs placebo.
- Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, double-blind trial
PubMed ID: 31500646
EMIQ (bioavailable rutin derivative) improved antioxidant index (BAP/d-ROMs) in athletes.
- Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome
PubMed ID: 10638663
ARDS trial (NAC + rutin) showed earlier reductions in lipid-peroxidation markers and ↑GSH—clinical biochemical antioxidant signal.
- Eating buckwheat cookies is associated with the reduction in serum levels of myeloperoxidase and cholesterol: a double blind crossover study in day-care centre staffs
PubMed ID: 21931228
High-rutin tartary buckwheat reduced myeloperoxidase (MPO), an oxidative/inflammatory marker (moderate direct evidence).
- The effects of rutin flavonoid supplement on glycemic status, lipid profile, atherogenic index of plasma, brain-derived neurotrophic factor (BDNF), some serum inflammatory, and oxidative stress factors in patients with type 2 diabetes mellitus: A double-blind, placebo-controlled trial
PubMed ID: 36101997
500 mg/day rutin reduced oxidative stress markers (MDA) and increased total antioxidant capacity.
Metabolism (3)
- The reduction impact of monoglucosyl rutin on abdominal visceral fat: A randomized, placebo-controlled, double-blind, parallel-group
PubMed ID: 32935866
Enzymatically modified water-soluble rutin reduced abdominal visceral fat area in an 8-week RCT.
- Eating buckwheat cookies is associated with the reduction in serum levels of myeloperoxidase and cholesterol: a double blind crossover study in day-care centre staffs
PubMed ID: 21931228
High-rutin tartary buckwheat lowered total and HDL cholesterol in a double-blind crossover (nutritional high-rutin intervention).
- The effects of rutin flavonoid supplement on glycemic status, lipid profile, atherogenic index of plasma, brain-derived neurotrophic factor (BDNF), some serum inflammatory, and oxidative stress factors in patients with type 2 diabetes mellitus: A double-blind, placebo-controlled trial
PubMed ID: 36101997
500 mg/day rutin in T2DM improved FBG, HbA1c, HOMA-IR and lipid markers in a placebo-controlled trial.
Skin health (3)
- Study of the soothing effects of troxerutin in alleviating skin sensitivity
PubMed ID: 38720512
Troxerutin produced prompt and preventive soothing effects on skin irritation and redness in clinical testing.
- Biological effects of rutin on skin aging
PubMed ID: 27220601
Topical rutin cream in a double‑blind human study improved skin elasticity and reduced wrinkle metrics over 4 weeks (direct evidence).
- Effects of topically applied antioxidants in experimentally provoked polymorphous light eruption
PubMed ID: 9529558
Topical alpha-glycosylrutin–containing creams lowered PLE severity and pruritus in susceptible subjects.
Joint comfort (2)
- Efficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugs
PubMed ID: 16539815
Rutoside-containing enzyme combo provided non-inferior symptomatic relief vs diclofenac in hip OA (moderate but confounded).
- Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee--a double-blind prospective randomized study
PubMed ID: 15278753
Rutoside-containing oral enzyme combo produced symptomatic improvement in knee OA comparable to diclofenac (moderate evidence, multi-ingredient product).
Eye health (2)
- Treatment of glaucomatous patients by means of food supplement to reduce the ocular discomfort: a double blind randomized trial
PubMed ID: 23661528
A supplement containing rutin improved ocular protection index and dry-eye symptoms in glaucoma patients using preserved drops (pilot RCT; multi-ingredient).
- A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin
PubMed ID: 7943118
Randomized double-masked trial in retinal vein occlusion: troxerutin improved visual acuity and reduced macular edema and RBC aggregability (strong ocular benefit signal).
Wellbeing (1)
- Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency
PubMed ID: 7975870
Meta-analysis showed modest improvements in symptoms (pain, swelling, tired legs) across trials—broad clinical benefit consistent with overall wellness.
Heart health (1)
- Fibrinolysis and hemorheology in chronic venous insufficiency: a double blind study of troxerutin efficiency
PubMed ID: 7593149
Troxerutin reduced RBC aggregation and improved fibrinolytic markers—mechanistic signals relevant to cardiovascular health.
Energy & Fatigue (1)
- Supplementation with Whey Protein, Omega-3 Fatty Acids and Polyphenols Combined with Electrical Muscle Stimulation Increases Muscle Strength in Elderly Adults with Limited Mobility: A Randomized Controlled Trial
PubMed ID: 32585837
Polyphenol (incl. rutin) addition improved muscle strength and gait speed in mobility‑limited elderly, implying functional energy benefits.
Allergy relief (1)
- Effects of topically applied antioxidants in experimentally provoked polymorphous light eruption
PubMed ID: 9529558
Topical antioxidant formulations containing an alpha-glycosylrutin derivative reduced photodermatosis (PLE) reactions and itch.
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Rutin
Search all1921 products whose verified label declares Rutin — not every bottle that mentions it in a title.
Being studied right now
Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet — this is what the field is asking, not what it found.